Remediation Template: Medication
Content Drugs for Neurological Disorders:
Parkinsonism and Alzheimer's Disease
Topic Descriptor Anticholinergics
Review Module Chapter 23
Medication biperiden HCI (Akineton)
Expected Pharmacological Action Blocks acetylcholine's action at cholinergic receptor sites.
This action restores the brains normal dopamine and acetylcholine balance, which relaxes muscle
movement and decreases rigidity and tremors. Biperiden amy also inhibit dopamine reuptake and
storage, which prolongs dopamine's action.
Therapeutic Uses
All types of parkinsonism
Side / Adverse Effects
Dry mouth, blurred vision, drowsiness, muscle
weakness, and constipation.
Medication / Food Interactions
None mentioned.
Note: Information obtained from text.
Nursing Interventions / Client Education
Nursing Interventions / Client Education
Monitor vital signs, urine output, and bowel
Encourage patient to ingest foods high in fiber
sounds. Caution patient to avoid driving and
and increase fluid intake to avoid constipation.
other activities until biperiden's CNS affects are
Client may use hard candy for dry mouth.
known. Emphasize the need for periodic eye
examinations and intraocular pressure
Note: Information obtained from text.
measurement because biperiden may cause
Nursing Administration
narrow angle glaucoma and increase
intraocular
pressure.
use diseaseAs an adjunct
to treatSuggest
all formsthe
of client
Parkinson's
sunglasses
in direct
because
Tablets: Adult
2 mg sunlight
t.i.d. or q.i.d.
up toof16 mg daily.
photophobia.
To control extrapyramiddal symptoms (except tardive dyskinesia) caused by phenoththiazines and other
Note:
Information
neuroleptic
drugs-obtained from 2012 Nurse's
Drug
Handbook
Tablets:
Adults 2and
mgText.
one to three times a daily.
I.V. or I.M. 2 mg repeated every 30 min. until symptoms resolve or maximum of four consecutive doses
in 24 hour is reached.
Evaluation of Medication Effectiveness
Assess muscle rigidity and tremor as baseline. Then check improvement, indicating biperiden's
Note: Information obtained from 2012 Nurse's Drug Handbook
effectiveness.
Note: Information obtained from 2012 Nurse's Drug Handbook
www.atitesting.com © 2010 Assessment Technologies Institute®, LLC